Inhibitory Effects of Beraprost Sodium in Murine Hepatic Sinusoidal Obstruction Syndrome.
Nakura M, Miyashita T, Yamamoto Y, Takada S, Kanou S, Tajima H, Takamura H, Ohta T.
Anticancer Res · journal article · DOI 10.21873/anticanres.14520 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för beraprost sodium. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
27 hitsPGI<sub>2</sub> Analog Attenuates Salt-Induced Renal Injury through the Inhibition of Inflammation and Rac1-MR Activation.
Hirohama D, Kawarazaki W, Nishimoto M, Ayuzawa N, Marumo T, Shibata S, Fujita T.
Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms21124433Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α.
Xu X, Pan X, Li S.
Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2019.8265Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria.
Choi YM, Kwon HS, Choi KM, Lee WY, Hong EG.
Endocrinol Metab (Seoul) · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.3803/enm.2019.34.4.398Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study.
Cai, Chen XP, Wei DC, Zhang Q, Chen SQ, He WZ.
J Int Med Res · clinical trial; research-article; journal article · DOI 10.1177/0300060519850401Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.
Li S, Wang Y, Chen L, Wang Z, Liu G, Zuo B, Liu C, Sun D.
J Mol Med (Berl) · research support, non-u.s. gov't; journal article; case reports · DOI 10.1007/s00109-019-01769-xComparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study.
Zhou Y, Du L, Tu B, Lai Q, Du X, Xu B, Zhang F, Zhao M, Wan Z, Lai J.
BMC Nephrol · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12882-018-1166-0Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways.
Deng J, Feng J, Liu T, Lu X, Wang W, Liu N, Lv Y, Liu Q, Guo C, Zhou Y.
Drug Des Devel Ther · research-article; journal article · DOI 10.2147/dddt.s182292Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up.
Wan Z, Zhu Y, Yang R, Zhang Y, Yang C, Cao L, Yan W, Wang Q, Li N, Zhao M, Gui K, Xiong M.
J Int Med Res · research-article; multicenter study; journal article · DOI 10.1177/0300060518800517Beraprost Sodium, a Stable Analogue of PGI2, Inhibits the Renin-Angiotensin System in the Renal Tissues of Rats with Chronic Renal Failure.
Wang XF, Zhang BH, Lu XQ, Wang P.
Kidney Blood Press Res · retracted publication; journal article · DOI 10.1159/000492405Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats.
Ahmad S, Panda BP, Fahim M, Dhyani N, Dubey K.
Iran J Pharm Res · research-article; journal articleA Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.
Takenaka M, Iio A, Sato R, Sakamoto T, Kurumatani H, KT-140 Clinical Study Group.
J Vet Intern Med · research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1111/jvim.14839Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke.
Chen S, Xie S, He W, Wei D, Li S, Chen W.
Med Sci Monit · research-article; journal article · DOI 10.12659/msm.902825Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway.
Zhang P, Xu L, Guan H, Liu L, Liu J, Huang Z, Cao X, Liao Z, Xiao H, Li Y.
Metabolism · research support, non-u.s. gov't; journal article · DOI 10.1016/j.metabol.2017.05.003Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.
Kim M, Kim JU, Kim SM, Kim H.
Int Urol Nephrol · journal article · DOI 10.1007/s11255-017-1586-yIdentification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K, Shimamura M, Seya K, Ando A, Miyamoto Y.
Eur J Drug Metab Pharmacokinet · journal article · DOI 10.1007/s13318-016-0327-4The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.
Shimamura M, Miyakawa J, Doi M, Okada K, Kurumatani H, Mori Y, Oshida K, Nakajo I, Oikawa K, Ushigome F, Miyashita A, Isono M, Miyamoto Y.
J Clin Pharmacol · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1002/jcph.835The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.
Peng L, Li J, Xu Y, Wang Y, Du H, Shao J, Liu Z.
Int J Endocrinol · research-article; journal article · DOI 10.1155/2016/1690474Beraprost sodium protects against chronic brain injury in aluminum-overload rats.
Pan Y, Yu L, Lei W, Guo Y, Wang J, Yu H, Tang Y, Yang J.
Behav Brain Funct · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12993-014-0051-7Beraprost Sodium Protects Against Diabetic Nephropathy in Patients with Arteriosclerosis Obliterans: A Prospective, Randomized, Open-label Study.
Shima A, Miyamoto M, Kubota Y, Takagi G, Shimizu W.
J Nippon Med Sch · randomized controlled trial; journal article · DOI 10.1272/jnms.82.84Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates lipopolysaccharide-induced cellular injury in lung alveolar epithelial cells.
Vicil S, Erdoğan S.
Turk J Med Sci · research support, non-u.s. gov't; journal article · DOI 10.3906/sag-1401-108Long-term survival of Japanese patients with pulmonary arterial hypertension treated with beraprost sodium, an oral prostacyclin analogue.
Sakao S, Tanabe N, Kasahara Y, Tatsumi K.
Intern Med · research support, non-u.s. gov't; journal article · DOI 10.2169/internalmedicine.53.2573Effects of beraprost sodium on renal function and inflammatory factors of rats with diabetic nephropathy.
Guan J, Long L, Chen YQ, Yin Y, Li L, Zhang CX, Deng L, Tian LH.
Genet Mol Res · journal article · DOI 10.4238/2014.june.9.1Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital.
Awsakulsutthi S, Punpho K, Mamom J, Baikrut P, Yingchoorod P.
Ann Vasc Dis · research-article; journal article · DOI 10.3400/avd.oa.13-00092Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy.
Na KY, Kim DK, Kim SG, Lee YK, Lim CS.
Trials · research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1186/1745-6215-14-275Effects of Beraprost sodium on subjective symptoms in diabetic patients with peripheral arterial disease.
Yoon HS, Choi WJ, Sung IH, Lee HS, Chung HJ, Lee JW.
Clin Orthop Surg · clinical trial; research-article; multicenter study; journal article · DOI 10.4055/cios.2013.5.2.145[Pharmacological profiles and clinical effects of oral sustained release beraprost sodium (Careload LA tablets 60 microg, Berasus LA tablets 60 microg)].
Kurumatani H.
Nihon Yakurigaku Zasshi · review; journal article · DOI 10.1254/fpj.133.101